Detalhe da pesquisa
1.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood
; 143(16): 1565-1575, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252906
2.
Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma.
Blood
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820500
3.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Blood
; 142(26): 2327-2331, 2023 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738563
4.
The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma.
Blood
; 140(4): 303-308, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580172
5.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
6.
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study.
Haematologica
; 109(4): 1184-1193, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646659
7.
Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721745
8.
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Br J Haematol
; 202(1): 116-121, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096954
9.
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma.
Blood
; 137(19): 2634-2645, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211842
10.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855051
11.
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Hematol Oncol
; 41(5): 884-893, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309225
12.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935098
13.
Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell Therapy.
Radiology
; 302(2): 438-445, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751616
14.
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines.
Hematol Oncol
; 40(4): 626-636, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644011
15.
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 790-800, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989558
16.
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma.
Br J Cancer
; 124(4): 744-753, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33311588
17.
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Blood
; 133(16): 1742-1752, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803990
18.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
19.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781267
20.
CAR T-Cell Therapy: An Update for Radiologists.
AJR Am J Roentgenol
; 217(6): 1461-1474, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34191544